We have measured activation-related epitopes of mTOR, 4E-BP1 and ribosomal protein S6, in conjunction with Ki-67 or the transferrin receptor CD71 and maturation markers, in primary cells of pre-treatment samples from patients with AML. This evidence concerns the gene MTOR and acute myeloid leukemia.